12/4
09:43 am
fbrx
Forte Biosciences, Inc. (NASDAQ: FBRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $64.00 price target on the stock.
Medium
Report
Forte Biosciences, Inc. (NASDAQ: FBRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $64.00 price target on the stock.
12/4
09:32 am
fbrx
Rating for FBRX
Medium
Report
Rating for FBRX
11/15
05:20 pm
fbrx
Rating for FBRX
Medium
Report
Rating for FBRX